Navigation Links
Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
Date:10/28/2008

xcept pursuant to an available exemption from such registration requirements.

Statements contained in this press release relating to future results, events or developments, including statements regarding the use of proceeds of the offering and the Company's partnering efforts, are "forward-looking statements" or "forward-looking information" under applicable United States and Canadian securities laws. Forward-looking statements and information can often be identified by the use of the words "believes," "may," "could", "plans," "will," "estimate," "continue," "anticipates," "intends," "expects", "goal" and similar expressions, Forward-looking statements or information are subject to the related assumptions made by us and involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from those expressed or implied by such statements or information.

Many of such risks, uncertainties and other factors form part of our underlying assumptions, and include, among other things, financial risks that would affect our operations such as our available working capital and cash flows and whether and for how long available funds will be sufficient to fund our operations and our ability to raise additional capital as and when needed; our need for substantial additional funding to conduct research and development and commercialization activities; changing facility costs and other risks relating to our facilities expansion plans; our ability to establish, and our dependence upon, relationships with strategic alliance partners to develop and commercialize products; technological changes that impact our existing products or our ability to develop and commercialize our products; our ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; our ability to obtain and maintain rights to technology from licensors; liability for paten
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 FMC Corporation’s Health ... for all current Epax® Ultra and Core concentrates ... Norway. The certification ensures the manufacturing process and ... Islamic religious regulations for Halal. , The ... efforts to further advance its customer service to ...
(Date:3/30/2015)... Angeles, CA (PRWEB) March 30, 2015 ... traditional blue polo for yellow to inspire courage in ... suffers from Severe Combined Immunodeficiency (SCID). SCID causes affected ... bone marrow transplant is needed to allow the development ... second transplant last Friday, created a video with his ...
(Date:3/30/2015)... 2015 GenSight ®, provider of ... as a leader in The Forrester Wave™: Strategic Planning ... , The independent report positions GenSight as a leader ... out of 5) for the analytics, corporate strategy, assessment, ... to GenSight’s position in the Leaders category. , According ...
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a sleek single-serve ... for reuse. Consumers simply twist the cup, turn it upward ... and basically anyone can now enjoy a non-alcoholic wine ... or pair with meals at work, home, or wherever the ... and that means Napa Wine grapes undergo the traditional wine ...
(Date:3/30/2015)... 30, 2015 The “Orthopedic ... EHR, Orthopedic PACS) By Applications (Orthopedic Surgery, ... Mode of Delivery] – Global Forecast to ... restraints and opportunities in North America, Europe, ... (RoW). , Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 ...
Breaking Medicine News(10 mins):Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4
... YORK, Dec. 30 Delcath Systems, Inc. (Nasdaq: ... host its quarterly update conference call at 4:30 PM ... President and Chief Executive Officer of Delcath Systems, will ... progress of patient enrollment and the advancement of clinical ...
... David B. Snow Jr., chairman and chief executive officer, Medco ... to address the Goldman Sachs Healthcare CEOs Unscripted: A View ... 7, 2009.The Medco presentation will begin at 11:15 a.m. EST ... to attend. Additionally, Snow will participate on a CEO ...
... exercise might help offset the effect, study suggests , , ... what appears to be a major mechanism contributing to ... that is amenable to change: rising blood glucose levels, ... Researchers reporting in the December issue of Annals ...
... the following Webcast: , , What: Neogen Corporation ... 2009 @ 11:00 EST, Where: http://www.videonewswire.com/event.asp?id=53900 , ... to the web at the address, ... Neogen Corporation, +1-800-234-5333., , If you are unable to ...
... December 30 , - Stubbing ... Your Child,GBP15,500 on Their 18th Birthday , ... ) is encouraging all parents who decide,to give up smoking ... they will save towards their children,s futures. , ...
... Committee for Quality,Assurance and the American Diabetes Association ... Barnett, M.D., Mirela Sturzu,M.D., Rudolf Teschan, M.D., and ... Recognition Program for providing quality care to,patients with ... and Zaki practice at the Aurora Health Center, ...
Cached Medicine News:Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Delcath Systems to Host Quarterly Update Conference Call 3Health News:Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference 2Health News:Rising Blood Sugar May Harm the Aging Brain 2Health News:Rising Blood Sugar May Harm the Aging Brain 3Health News:Urging New Year Quitters to Invest in Their Family's Futures 2Health News:Aurora Physicians Receive National Recognition for Quality Diabetes Care 2
(Date:3/30/2015)... 30, 2015 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based ... announced its unaudited financial results for the fourth ... Financial HighlightsFor the quarter ended December 31, 2014: ... compared to the fourth quarter of 2013 ...
(Date:3/27/2015)... 2015 Across the global healthcare landscape, the ... clinical development, market education, and regulatory compliance. As emerging ... function is expected to increase in prominence and follow ... According to research by benchmarking firm, Best Practices, LLC, ... to Medical Affairs. Among companies in India ...
(Date:3/27/2015)... Levi & Korsinsky announces it has commenced ... ) concerning possible violations of federal securities laws. The ... connection with its study of the drug OHR-102. To ... contact Joseph E. Levi, Esq. either via ... (212) 363-7500, toll-free: (877) 363-5972. Levi & ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 11China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 12China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 13China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 14China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 15Medical Affairs Capabilities Expanding in Emerging Marketplaces 2
... SANTA BARBARA, Calif., June 20, 2011 Inogen has ... (MDEA) for the Inogen One Portable Oxygen Concentrator.  The ... program that exclusively recognizes contributions and advances in the ... One, developed by Goleta, California based Inogen, Inc. is ...
... 2011 The U.S. Food and Drug Administration today ... and approval of an artificial pancreas system to treat ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Type ... pancreas produces little or no insulin, a hormone needed ...
Cached Medicine Technology:Inogen One Wins Gold Medical Design Excellence Award 2FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 2FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 3
... single use suturing device has application ... of interrupted or running stitches in ... use suturing device is available in ... with the choice of 4 suture ...
... of a 42" long suture inserted into a ... one end and scored on the other. The ... to a ST-3 needle. The opposite end of ... of the plastic tube. The scored end acts ...
This ENDOLOOP suture has a suture type - 0 MONOCRYL and a 1.5 inch diameter....
... inserted into a plastic tube. The plastic tube is ... The suture protrudes from the narrow end and is ... becomes secure after the device is activated. The opposite ... end of the plastic tube. The scored end acts ...
Medicine Products: